Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soldano Ferrone

Showing results (131-140 of 334) with videos related to

Pageof 34
Sort By:
International Journal of Cancer|January 30, 2004
MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinomaDerek Atkins, Aldona Breuckmann, Gerd E Schmahl, et al.
Surgery|December 26, 2006
Expression and prognostic significance of prothymosin-alpha and ERp57 in human gastric cancerCharles M Leys, Sachiyo Nomura, Bonnie J LaFleur, et al.
Translational Oncology|October 2, 2025
HDAC inhibitor (SAHA) enhances B7-H3-specific CAR T cell cytotoxic efficacy against chondrosarcoma cells and prolongs survival in an orthotopic mouse modelDavid O Osei-Hwedieh, Lile He, Kun Wang, et al.
Frontiers in Oncology|July 24, 2023
B7-H3-targeted CAR T cell activity is enhanced by radiotherapy in solid cancersMarco Ventin, Giulia Cattaneo, Luke Maggs, et al.
Journal of Neuro-Oncology|January 20, 2009
Expression of HMP/AN2, a melanoma associated antigen, in murine cerebral gliomas: potential for radioimmunotargetingAsit K Paul, Michael J Ciesielski, Munawwar Sajjad, et al.
Cancer Letters|June 1, 2005
Mechanisms of immune evasion of human neuroblastomaLizzia Raffaghello, Ignazia Prigione, Irma Airoldi, et al.
International Journal of Cancer|February 1, 2013
Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell deathJames W Hodge, Charlie T Garnett, Benedetto Farsaci, et al.
Cancer Immunology, Immunotherapy : CII|October 13, 2009
Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancerBarbara Seliger, Robert Stoehr, Diana Handke, et al.
Cancer Immunology, Immunotherapy : CII|January 20, 2012
Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancerEmilia Andersson, Lisa Villabona, Kjell Bergfeldt, et al.
Anti-Cancer Agents in Medicinal Chemistry|January 1, 2013
Multidisciplinary approach to patient with malignant melanomaGiuseppina Della Vittoria Scarpati, Celeste Fusciello, Francesco Sabbatino, et al.
Pageof 34

Showing results (131-140 of 334) with videos related to

Sort By:
Pageof 34
International Journal of Cancer|January 30, 2004
MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinomaDerek Atkins, Aldona Breuckmann, Gerd E Schmahl, et al.
Surgery|December 26, 2006
Expression and prognostic significance of prothymosin-alpha and ERp57 in human gastric cancerCharles M Leys, Sachiyo Nomura, Bonnie J LaFleur, et al.
Translational Oncology|October 2, 2025
HDAC inhibitor (SAHA) enhances B7-H3-specific CAR T cell cytotoxic efficacy against chondrosarcoma cells and prolongs survival in an orthotopic mouse modelDavid O Osei-Hwedieh, Lile He, Kun Wang, et al.
Frontiers in Oncology|July 24, 2023
B7-H3-targeted CAR T cell activity is enhanced by radiotherapy in solid cancersMarco Ventin, Giulia Cattaneo, Luke Maggs, et al.
Journal of Neuro-Oncology|January 20, 2009
Expression of HMP/AN2, a melanoma associated antigen, in murine cerebral gliomas: potential for radioimmunotargetingAsit K Paul, Michael J Ciesielski, Munawwar Sajjad, et al.
Cancer Letters|June 1, 2005
Mechanisms of immune evasion of human neuroblastomaLizzia Raffaghello, Ignazia Prigione, Irma Airoldi, et al.
International Journal of Cancer|February 1, 2013
Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell deathJames W Hodge, Charlie T Garnett, Benedetto Farsaci, et al.
Cancer Immunology, Immunotherapy : CII|October 13, 2009
Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancerBarbara Seliger, Robert Stoehr, Diana Handke, et al.
Cancer Immunology, Immunotherapy : CII|January 20, 2012
Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancerEmilia Andersson, Lisa Villabona, Kjell Bergfeldt, et al.
Anti-Cancer Agents in Medicinal Chemistry|January 1, 2013
Multidisciplinary approach to patient with malignant melanomaGiuseppina Della Vittoria Scarpati, Celeste Fusciello, Francesco Sabbatino, et al.
Pageof 34